TY - JOUR
T1 - Defining dry eye from a clinical perspective
AU - Tsubota, Kazuo
AU - Pflugfelder, Stephen C.
AU - Liu, Zuguo
AU - Baudouin, Christophe
AU - Kim, Hyo Myung
AU - Messmer, Elisabeth M.
AU - Kruse, Friedrich
AU - Liang, Lingyi
AU - Carreno-Galeano, Jimena Tatiana
AU - Rolando, Maurizio
AU - Yokoi, Norihiko
AU - Kinoshita, Shigeru
AU - Dana, Reza
N1 - Funding Information:
Funding: This research was funded by Asia Dry Eye Society and, for N.Y., “Grants-in-Aid for scientific research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (Grant number: 16K11269).
Funding Information:
Acknowledgments: N. Yokoi wishes to thank John Bush (Dept. of Foreign Affairs, Kyoto Prefectural University of Medicine, Kyoto, Japan) for reviewing part of the manuscript. Editorial support was provided by Synergy Vision (London, UK) and funded by the Asia Dry Eye Society. The authors wish to thank Catherine Oshima (Keio University) for providing administrative support.
Publisher Copyright:
© 2020 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2020/12/1
Y1 - 2020/12/1
N2 - Over the past decades, the number of patients with dry eye disease (DED) has increased dramatically. The incidence of DED is higher in Asia than in Europe and North America, suggesting the involvement of cultural or racial factors in DED etiology. Although many definitions of DED have been used, discrepancies exist between the various definitions of dry eye disease (DED) used across the globe. This article presents a clinical consensus on the definition of DED, as formulated in four meetings with global DED experts. The proposed new definition is as follows: “Dry eye is a multifactorial disease characterized by a persistently unstable and/or deficient tear film (TF) causing discomfort and/or visual impairment, accompanied by variable degrees of ocular surface epitheliopathy, inflammation and neurosensory abnormalities.” The key criteria for the diagnosis of DED are unstable TF, inflammation, ocular discomfort and visual impairment. This definition also recommends the assessment of ocular surface epitheliopathy and neurosensory abnormalities in each patient with suspected DED. It is easily applicable in clinical practice and should help practitioners diagnose DED consistently. This consensus definition of DED should also help to guide research and clinical trials that, to date, have been hampered by the lack of an established surrogate endpoint.
AB - Over the past decades, the number of patients with dry eye disease (DED) has increased dramatically. The incidence of DED is higher in Asia than in Europe and North America, suggesting the involvement of cultural or racial factors in DED etiology. Although many definitions of DED have been used, discrepancies exist between the various definitions of dry eye disease (DED) used across the globe. This article presents a clinical consensus on the definition of DED, as formulated in four meetings with global DED experts. The proposed new definition is as follows: “Dry eye is a multifactorial disease characterized by a persistently unstable and/or deficient tear film (TF) causing discomfort and/or visual impairment, accompanied by variable degrees of ocular surface epitheliopathy, inflammation and neurosensory abnormalities.” The key criteria for the diagnosis of DED are unstable TF, inflammation, ocular discomfort and visual impairment. This definition also recommends the assessment of ocular surface epitheliopathy and neurosensory abnormalities in each patient with suspected DED. It is easily applicable in clinical practice and should help practitioners diagnose DED consistently. This consensus definition of DED should also help to guide research and clinical trials that, to date, have been hampered by the lack of an established surrogate endpoint.
KW - Corneal epitheliopathy
KW - Definition
KW - Dry eye
KW - Dry eye signs
KW - Dry eye symptoms
KW - Inflammation
KW - Neuropathic pain
KW - Tear film breakup
UR - http://www.scopus.com/inward/record.url?scp=85097395913&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85097395913&partnerID=8YFLogxK
U2 - 10.3390/ijms21239271
DO - 10.3390/ijms21239271
M3 - Review article
C2 - 33291796
AN - SCOPUS:85097395913
SN - 1661-6596
VL - 21
SP - 1
EP - 24
JO - International Journal of Molecular Sciences
JF - International Journal of Molecular Sciences
IS - 23
M1 - 9271
ER -